How much does Fruquintinib cost in medical insurance?

Fruquintinib (Fruquintinib) is an oral small molecule targeted therapy drug that belongs to a class of multicaseokinase inhibitors. It is mainly used to treat advanced gastric and colorectal cancer, especially those who have received other treatments or have metastases.

Fruquintinib is a drug developed in Hong Kong, China. It has been approved for marketing by the State Food and Drug Administration and has been included in medical insurance. Patients can buy it in domestic hospital pharmacies at a price of about one to two thousand. For specific prices, please consult the local hospital pharmacy.

Its mechanism of action is mainly through inhibiting the activity of vascular endothelial growth factor receptor (VEGFR), of which VEGFR includes VEGFR-1, VEGFR-2 and VEGFR-3. By interfering with the signaling pathways of these receptors, fruquintinib can inhibit the formation and growth of tumor blood vessels, thereby reducing the tumor's dependence on blood supply and achieving the effect of inhibiting tumor growth and spread.

Clinical studies have shown that fruquintinib has significant efficacy in the treatment of advanced colorectal cancer and gastric cancer. After patients receive fruquintinib treatment, they can often observe tumor shrinkage and improvement of their condition, thereby improving the patient's survival rate and survival period.

Although fruquintinib has shown good results in anti-cancer treatment, it also has some potential side effects, such as hypertension, hand-foot syndrome, proteinuria, etc. Therefore, when treating with fruquintinib, physicians need to carefully evaluate the patient's physical condition, monitor the patient's response, and make dose adjustments or discontinuation as needed.

Overall, fruquintinib, as a targeted therapy, has demonstrated potential clinical value in the treatment of advanced gastric cancer and colorectal cancer. However, its specific treatment plan should be formulated by professional doctors based on the patient's specific situation to ensure the best treatment effect and patient quality of life.